Harel Insurance Investments & Financial Services Ltd. Biogen Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$6.11 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$275.25 - $318.06 $56,701 - $65,520	-206 Reduced 44.69%	255 $72,000
Q1 2023 May 02, 2023	BUY	$256.56 - $292.34 $31,556 - $35,957	123 Added 36.39%	461 $127,000
Q4 2022 Jan 26, 2023	SELL	$252.44 - $306.72 $369,067 - $448,424	-1,462 Reduced 81.22%	338 $93,000
Q3 2022 Oct 31, 2022	BUY	$194.69 - $268.46 $350,442 - $483,227	1,800 New	1,800 $476,000
Q1 2022 May 03, 2022	SELL	$193.77 - $244.14 $775 - $976	-4 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $36,722 - $47,194	-164 Reduced 97.62%	4 $1,000
Q3 2021 Oct 25, 2021	BUY	$282.99 - $369.05 $9,904 - $12,916	35 Added 26.32%	168 $48,000
Q1 2021 Apr 27, 2021	SELL	$242.95 - $284.63 $381,674 - $447,153	-1,571 Reduced 92.19%	133 $37,000
Q4 2020 Jan 26, 2021	SELL	$236.26 - $355.63 $31,422 - $47,298	-133 Reduced 7.24%	1,704 $1.34 Million
Q3 2020 Oct 20, 2020	BUY	$264.77 - $305.71 $192,752 - $222,556	728 Added 65.64%	1,837 $521,000
Q2 2020 Jul 14, 2020	BUY	$258.66 - $342.55 $4,138 - $5,480	16 Added 1.46%	1,109 $297,000
Q1 2020 Apr 28, 2020	BUY	$268.85 - $341.04 $104,313 - $132,323	388 Added 55.04%	1,093 $346,000
Q4 2019 Jan 23, 2020	BUY	$220.06 - $304.07 $115,971 - $160,244	527 Added 296.07%	705 $209,000
Q3 2019 Nov 06, 2019	BUY	$217.44 - $243.88 $38,704 - $43,410	178 New	178 $41,000
Q2 2019 Jul 22, 2019	SELL	$219.29 - $241.72 $21,929 - $24,172	-100 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$216.71 - $338.96 $151,697 - $237,272	-700 Reduced 87.5%	100 $24,000
Q4 2018 Jan 29, 2019	SELL	$278.5 - $352.75 $250,650 - $317,475	-900 Reduced 52.94%	800 $241,000
Q3 2018 Oct 29, 2018	BUY	$293.51 - $383.83 $322,861 - $422,213	1,100 Added 183.33%	1,700 $601,000
Q2 2018 Jul 30, 2018	BUY	$257.52 - $306.91 $51,504 - $61,382	200 Added 50.0%	600 $174,000
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $53,529 - $59,956	174 Added 76.99%	400 $127,000
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $63,539 - $74,509	226	226 $71,000

Others Institutions Holding BIIB

# of Institutions

1,006

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account